Literature DB >> 12381460

Adjuvant properties and colonization potential of adhering and non-adhering Lactobacillus spp following oral administration to mice.

Laura J Plant1, Patricia L Conway.   

Abstract

This study aimed to determine whether adhesive strains of Lactobacillus possessed an increased ability to colonize the gastrointestinal tract and to examine the adjuvant capacities of these strains for the 50000 molecular-mass fragment C of tetanus toxin (TTFC) following oral administration. The three strains used in this study showed different patterns of adhesion to tissue from all regions of the gastrointestinal tract, with two strains adhering in high numbers and one strain showing negligible association with all tissue types. The colonization patterns in the gastrointestinal tract of C57BL/6 mice following oro-gastric dosing was also monitored, and it was found that adhesive Lactobacillus strains could be detected for at least 24 h, in association with either fecal material and/or with gastrointestinal tissue or contents. In addition, mice were given an oro-gastric dose of the lactobacilli (5 x 10(8) colony forming units) with TTFC (10 and 50 micro g), and the serum-specific IgM and IgG antibody responses monitored in serum. The adhesive strains, which persisted within the gastrointestinal tract for at least 24 h, showed enhanced antigen-specific serum IgG and IgM antibody responses in comparison to a non-adhesive strain that failed to be detected in the gastrointestinal tract. Adhesion to the gastrointestinal tract is a factor affecting the capacity of lactobacilli to persist within the gastrointestinal tract and to act as an adjuvant for orally administered antigen.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12381460     DOI: 10.1111/j.1574-695X.2002.tb00610.x

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  7 in total

1.  Mucosal and systemic immune responses induced by recombinant Lactobacillus spp. expressing the hemagglutinin of the avian influenza virus H5N1.

Authors:  Zhisheng Wang; Qinghua Yu; Junkai Gao; Qian Yang
Journal:  Clin Vaccine Immunol       Date:  2011-11-30

2.  Potential Evaluation and Health Fostering Intrinsic Traits of Novel Probiotic Strain Enterococcus durans F3 Isolated from the Gut of Fresh Water Fish Catla catla.

Authors:  Eyad Alshammari; Mitesh Patel; Manojkumar Sachidanandan; Prashant Kumar; Mohd Adnan
Journal:  Food Sci Anim Resour       Date:  2019-10-31

3.  Development of a Dairy-Free Fermented Oat-Based Beverage With Enhanced Probiotic and Bioactive Properties.

Authors:  Liwei Chen; Daoyan Wu; Joergen Schlundt; Patricia L Conway
Journal:  Front Microbiol       Date:  2020-12-03       Impact factor: 5.640

Review 4.  Probiotic-Based Vaccines May Provide Effective Protection against COVID-19 Acute Respiratory Disease.

Authors:  Sedigheh Taghinezhad-S; Amir Hossein Mohseni; Luis G Bermúdez-Humarán; Vincenzo Casolaro; Naima G Cortes-Perez; Hossein Keyvani; Jesus Simal-Gandara
Journal:  Vaccines (Basel)       Date:  2021-05-06

5.  Biomedical applications of fermenticin HV6b isolated from Lactobacillus fermentum HV6b MTCC10770.

Authors:  Baljinder Kaur; Praveen P Balgir; Bharti Mittu; Balvir Kumar; Neena Garg
Journal:  Biomed Res Int       Date:  2013-07-29       Impact factor: 3.411

6.  Factors that Influence the Immunological Adjuvant Effect of Lactobacillus fermentum PC1 on Specific Immune Responses in Mice to Orally Administered Antigens.

Authors:  Meera Esvaran; Patricia L Conway
Journal:  Vaccines (Basel)       Date:  2016-07-19

7.  Induction of systemic and mucosal immune response and decrease in Streptococcus pneumoniae colonization by nasal inoculation of mice with recombinant lactic acid bacteria expressing pneumococcal surface antigen A.

Authors:  Maria Leonor Sarno Oliveira; Ana Paula Mattos Arêas; Ivana Barros Campos; Vicente Monedero; Gaspar Perez-Martínez; Eliane Namie Miyaji; Luciana Cezar Cerqueira Leite; Karina Araújo Aires; Paulo Lee Ho
Journal:  Microbes Infect       Date:  2006-01-18       Impact factor: 2.700

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.